search
Back to results

Locally Delivered Antibiotics for the Treatment of Periodontitis

Primary Purpose

Periodontitis

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Minocycline Topical
Metronidazole Topical Gel
Sponsored by
Riyadh Elm University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Periodontitis

Eligibility Criteria

25 Years - 50 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Patients suffering from chronic periodontitis with almost similar probing depth bilaterally (≥
  • 6 mm) at the selected sites and exhibiting bleeding on probing Patients with no caries and restorations on the selected teeth
  • Patients showing effective individual oral hygiene.

Exclusion Criteria:

Patients presenting with history of intake of local and/or systemic antibiotic therapy for the last 3 months

  • Patients with known systemic and debilitating diseases (Muscular Dystrophy)
  • Patients presenting with known adverse reactions to any component of the test agent
  • Patients on anticoagulant therapy
  • Pregnant and lactating females
  • Smokers
  • Patients in a regular use of mouth wash

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Experimental

    Arm Label

    Mincycline hydrochloride 2% oral gel

    Metronidazole hylcate 0.75 % oral gel

    Arm Description

    Minocycline will be delivered locally in the periodontal pocket.

    Metronidazole gel will be delivered locally in the periodontal pocket.

    Outcomes

    Primary Outcome Measures

    plaque index
    To measure the state of oral hygiene as: 0 = No plaque in the gingival area = A film of plaque adhering to the free gingival margin and adjacent of the tooth = Moderate accumulation of soft deposits within the gingival pocket = Abundance of soft matter within the gingival pocket The Plaque Index is the four gingival areas of the tooth (buccal, lingual/palatal, mesial, distal) given a score from 0-3 and scores were added and divided by four. The plaque index for the individual was obtained by adding the indices for the teeth and divide by the number of teeth examined.
    gingival index
    To assess the gingival condition and record qualitative chances in the gingiva as: 0 = Normal gingiva = Mild inflammation - slight change in color and slight edema but no bleeding on probing. = Moderate inflammation - redness, edema and glazing, bleeding on probing = Severe inflammation - marked redness and edema, ulceration with tendency to spontaneous bleeding. The bleeding will be assessed by gently probing along the wall of the soft tissue of the gingival sulcus. To get the gingival index for the tooth, the four areas of the tooth (buccal, lingual/palatal, mesial, distal) are scored by the sum and divided by four. The gingival index for the individual will be obtained by adding the indices of the teeth and divided by the number of teeth examined.
    probing depth
    The distance from the gingival margin to base of the sulcus. Will be measured at six sites per tooth (mesio-buccal, buccal, disto-buccal, disto-lingual, lingual and mesio-lingual) at all teeth with UNC-15 probe.
    IL6
    In healthy subjects it ranges from 0.5-5 pg/ml In eosinophilic subjects it ranges from 3-18pg/ml in plasma

    Secondary Outcome Measures

    Full Information

    First Posted
    October 11, 2019
    Last Updated
    October 13, 2019
    Sponsor
    Riyadh Elm University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04125706
    Brief Title
    Locally Delivered Antibiotics for the Treatment of Periodontitis
    Official Title
    Locally Delivered Antibiotics for the Treatment of Periodontitis Topical Doxycycline Versus Minocycline Gels as an Adjunct to Mechanical Treatment
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2019
    Overall Recruitment Status
    Unknown status
    Study Start Date
    November 1, 2019 (Anticipated)
    Primary Completion Date
    July 1, 2020 (Anticipated)
    Study Completion Date
    September 1, 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Riyadh Elm University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The sample consists of patients with moderate to severe periodontitis who will be subjected to machanical therapy in combination to local antibiotics. The participants will be divided into two groups, mechanical therapy with metronidazole hyclate, and mechanical therapy with minocycline hydrochloride. Both antibiotics will be delivered locally as gels. Outcome measures include probing pocket depth and several gingival indices. IL6 will be also measured for all participants.
    Detailed Description
    Forty-four patients in the age group of 25-50 years (males and females) who are suffering from periodontitis with almost similar probing depth bilaterally (≥ 6 mm) at the selected sites and exhibiting bleeding on probing. A written informed consent will be taken from the patients prior to the study. Each patient will be recalled 4 weeks after completion of both sides supra-gingival scaling, which formed the baseline visit. Plaque scores will be brought to zero, and the probing pocket depth and gingival index, will be recorded on the proforma specially prepared for the purpose. The selected treatment sites will be then divided into two groups, and sub-gingival SRP will be performed prior to the delivery of the drugs at the test sites. Group I: Consist of periodontal pockets on the left side of maxillary or mandibular arch and received sub-gingival Minocycline 2% gel. Group II: Consist of periodontal pockets on the left side of maxillary or mandibular arch and received Metronidazole 0.75% gel. The right side will be left as a control in both groups Patients will be recalled after 6 weeks from the baseline visit to record the plaque index, gingival index, bleeding index and probing depth (UNC probe 12 mm). Statistical Analysis: The unit of measurement in this study is the site, rather than the subject. Student-t test was To compare between Group 1 (Minocycline 2 %) and Group 2 (Metronidazole 0.75 %), Data will check for normality, if the data normally distributed Independent t-test will use to test if there any significant differences between groups, otherwise if not normally Mann -Whitney U-test (Non-parametric) will use to detects the difference. To achieve 80% power of statistical test to detect the differences between Metronidazole and Minocycline With 5 % level of significant, 19.6 reduction in probing depth (previous study-vi) and standard deviation of 0.23, using the following formula. n=(2σ^2 〖(Z_(β+Z_(1-α/2) ))〗^2)/d^2 22 per group (minimum sample size) where: σ =0.23 Zβ =0.84 Z(1-α/2) =1.96, d= 19.6% For objective 2, the statistical test in case of normal data distribution will be paired t test or will use Willcoxon Sign Ranked test if it not normally distributed. To achieve 80% power of statistical test to detect the differences between Metronidazole and Minocycline. With 5% level of significant.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Periodontitis

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Two parallel groups will receive two different locally delivered antibiotics
    Masking
    ParticipantCare ProviderInvestigatorOutcomes Assessor
    Masking Description
    Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
    Allocation
    Randomized
    Enrollment
    44 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Mincycline hydrochloride 2% oral gel
    Arm Type
    Experimental
    Arm Description
    Minocycline will be delivered locally in the periodontal pocket.
    Arm Title
    Metronidazole hylcate 0.75 % oral gel
    Arm Type
    Experimental
    Arm Description
    Metronidazole gel will be delivered locally in the periodontal pocket.
    Intervention Type
    Drug
    Intervention Name(s)
    Minocycline Topical
    Other Intervention Name(s)
    Dentomycin oral gel will be delivered locally in the periodontal pocket
    Intervention Description
    Minocycline will be delivered locally in the periodontal pocket
    Intervention Type
    Drug
    Intervention Name(s)
    Metronidazole Topical Gel
    Other Intervention Name(s)
    Roza 0.75% will be delivered locally in the periodontal pocket
    Intervention Description
    Metronidazole will be delivered locally in the periodontal pocket
    Primary Outcome Measure Information:
    Title
    plaque index
    Description
    To measure the state of oral hygiene as: 0 = No plaque in the gingival area = A film of plaque adhering to the free gingival margin and adjacent of the tooth = Moderate accumulation of soft deposits within the gingival pocket = Abundance of soft matter within the gingival pocket The Plaque Index is the four gingival areas of the tooth (buccal, lingual/palatal, mesial, distal) given a score from 0-3 and scores were added and divided by four. The plaque index for the individual was obtained by adding the indices for the teeth and divide by the number of teeth examined.
    Time Frame
    Baseline to six weeks
    Title
    gingival index
    Description
    To assess the gingival condition and record qualitative chances in the gingiva as: 0 = Normal gingiva = Mild inflammation - slight change in color and slight edema but no bleeding on probing. = Moderate inflammation - redness, edema and glazing, bleeding on probing = Severe inflammation - marked redness and edema, ulceration with tendency to spontaneous bleeding. The bleeding will be assessed by gently probing along the wall of the soft tissue of the gingival sulcus. To get the gingival index for the tooth, the four areas of the tooth (buccal, lingual/palatal, mesial, distal) are scored by the sum and divided by four. The gingival index for the individual will be obtained by adding the indices of the teeth and divided by the number of teeth examined.
    Time Frame
    Baseline to six weeks
    Title
    probing depth
    Description
    The distance from the gingival margin to base of the sulcus. Will be measured at six sites per tooth (mesio-buccal, buccal, disto-buccal, disto-lingual, lingual and mesio-lingual) at all teeth with UNC-15 probe.
    Time Frame
    Baseline to six weeks
    Title
    IL6
    Description
    In healthy subjects it ranges from 0.5-5 pg/ml In eosinophilic subjects it ranges from 3-18pg/ml in plasma
    Time Frame
    Baseline to six weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    25 Years
    Maximum Age & Unit of Time
    50 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Patients suffering from chronic periodontitis with almost similar probing depth bilaterally (≥ 6 mm) at the selected sites and exhibiting bleeding on probing Patients with no caries and restorations on the selected teeth Patients showing effective individual oral hygiene. Exclusion Criteria: Patients presenting with history of intake of local and/or systemic antibiotic therapy for the last 3 months Patients with known systemic and debilitating diseases (Muscular Dystrophy) Patients presenting with known adverse reactions to any component of the test agent Patients on anticoagulant therapy Pregnant and lactating females Smokers Patients in a regular use of mouth wash
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Sasha M Suliman, MSc
    Phone
    966533215808
    Email
    sashasuliman@riyadh.edu.sa
    First Name & Middle Initial & Last Name or Official Title & Degree
    Omer AlKadhi
    Email
    Omar.AlKadhi@riyadh.edu.sa
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Sasha M Suliman, MSc
    Organizational Affiliation
    Ar Riyad, Saudi Arabia, 11681
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Locally Delivered Antibiotics for the Treatment of Periodontitis

    We'll reach out to this number within 24 hrs